• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SRx Health Enters into Definitive Agreement to Acquire EMJX to Establish Next-Generation Digital Asset Treasury Operating System and Platform Led by Eric M. Jackson

    12/16/25 8:30:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples
    Get the next $SRXH alert in real time by email

    NORTH PALM BEACH, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced that it has entered into a definitive agreement to acquire EMJ Crypto Technologies ("EMJX"), a digital-asset treasury platform designed as a treasury operating system, applying quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Upon completion of the transaction, Eric M. Jackson, Ph.D., Founder and Chief Executive Officer of EMJX, is expected to serve as Chief Executive Officer and Chairman of the combined company.

    A Gen2 Approach to Digital Asset Treasuries:

    EMJX is designed as a next-generation ("Gen2") digital-asset treasury platform, differentiated from earlier "Gen1" treasury models that primarily hold a single digital asset on a passive basis. EMJX's Gen2 approach is structured as a platform that governs how capital is allocated, hedged, and reinvested across market cycles, rather than functioning as a passive balance sheet tracking asset values. Gen1 treasury approaches largely rely on price appreciation of a single asset and typically lack systematic risk management, which can expose shareholders to significant drawdowns and dilution during adverse market conditions.

    By contrast, EMJX is structured to support:

    • multi-asset digital holdings,
    • quantitative and AI-informed decision-making, and
    • systematic risk management across market regimes, with the objective of managing treasury exposure through periods of both market expansion and contraction.

    The Company believes this Gen2 framework reflects the continued maturation of digital-asset treasuries toward more disciplined, institutional-grade capital management models.

    Eric M. Jackson, Founder and CEO of EMJX, said, "Every major technology category goes through generational transitions. In digital assets, we believe the next phase is defined by disciplined risk management and multi-asset flexibility rather than single-asset exposure alone. Many digital-asset treasuries today function more like passive markers in the market — they rise and fall with price movements. EMJX is designed to operate more like a vessel with navigation systems, applying quantitative models and AI-enabled risk controls to help manage volatility across market cycles. Our objective is to reinvest capital back into the treasury over time rather than rely on dilution, and to build a transparent, institutional-grade platform with a long-term orientation. Platforms aren't valued on what they hold – they're valued on what they enable."

    Capital Discipline and Treasury Compounding:

    As a treasury operating system, EMJX is designed to manage risk and capital allocation at the system level rather than through asset-by-asset trading. The platform applies quantitative risk-management tools, including hedging strategies, with the objective of mitigating drawdowns during periods of market stress.

    When these risk-management activities generate excess capital, the Company intends to allocate that capital back into its digital-asset treasury rather than relying on equity issuance, subject to market conditions, governance oversight, and regulatory considerations. The Company believes this approach may allow the treasury to compound over time while reducing the need for shareholder dilution that has historically accompanied single-asset, unhedged treasury models.

    Founder Track Record and Market Insight:

    EMJX was founded by Eric M. Jackson, Ph.D., a long-time technology investor and market analyst known for identifying inflection points in misunderstood public companies before they became widely recognized.

    Over the past several years, Dr. Jackson publicly identified and analyzed a number of non-consensus opportunities that later experienced significant market re-ratings, including Carvana, Opendoor, Better Home & Finance, and Nextdoor. His work around Opendoor helped catalyze a large, engaged retail investor community commonly referred to as the "OPEN Army," which emphasized long-term conviction, transparency, and platform-level analysis over short-term trading.

    That same analytical framework underpins the Rising Dynasty philosophy — a research-driven approach focused on power-law outcomes, structural change, and disciplined risk awareness. EMJX applies these principles to the digital-asset treasury space through quantitative systems rather than discretionary positioning.

    Dr. Jackson is a frequent commentator on technology and market structure and has appeared on major financial media outlets including CNBC, Bloomberg, and Fox Business.

    Platform Development:

    EMJX's digital-asset treasury operating system is powered by its proprietary Quantitative AI and Machine Learning (QAM) Engine, which has been developed and refined since 2021. The QAM Engine is designed to analyze market conditions and inform portfolio-level risk-management decisions across multiple digital assets, subject to governance and oversight.

    The Company emphasizes that the platform's objective is risk-aware treasury management, not short-term speculation.

    Strategic Rationale:

    The transaction is intended to position the combined company at the intersection of:

    • digital-asset treasury management,
    • quantitative and AI-enabled risk systems, and
    • public-market transparency and governance.

    The Company believes digital-asset treasuries are entering a new phase, where survivability through volatility, disciplined capital allocation, and long-term compounding — rather than simple asset exposure — become the defining competitive advantages. The Company believes the long-term value of EMJX will be driven not by the digital assets held at any point in time, but by the risk-management, capital-routing, and compounding capabilities the platform enables over full market cycles.

    Transaction Details:

    • The SRx Health Board of Directors has unanimously approved the transaction.
    • The transaction is subject to approval by SRx Health shareholders and other customary closing conditions.
    • Closing is expected during the first quarter of 2026.
    • Until closing, SRx Health shares will continue to trade on NYSE American under the symbol "SRXH."
    • Following completion, the combined company expects to operate under the EMJX name and intends to pursue a ticker symbol change, subject to exchange approval.

    About EMJX

    EMJX is a Gen2 digital-asset treasury operating system designed to manage multi-asset digital holdings using quantitative models, artificial intelligence, and systematic risk controls. The platform emphasizes transparency, governance, and disciplined capital allocation across varying market environments. For more information, please visit www.emjx.ai.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "believe," "expect," "intend," "aim," "plan," "may," "could," "target," and similar expressions are intended to identify forward-looking statements. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals, market conditions, regulatory considerations, and other risks described in the Company's filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except as required by law.

    Company Contact

    SRx Health Solutions, Inc.

    Kent Cunningham, Chief Executive Officer

    Investor Relations

    KCSA Strategic Communications

    Valter Pinto, Managing Director

    212-896-1254

    [email protected]

    Media Contact

    KCSA Strategic Communications

    Kristin Cwalinski, Senior Vice President

    [email protected]



    Primary Logo

    Get the next $SRXH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SRXH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SRXH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director White David Allan was granted 344,975 shares, decreasing direct ownership by 97% to 6,200 units (SEC Form 4)

    4 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    10/7/25 1:46:23 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    New insider Vora Adesh Anil claimed ownership of 325,279 shares (SEC Form 3)

    3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    5/7/25 4:57:50 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    New insider Sohi Davender claimed ownership of 99,038 shares (SEC Form 3)

    3 - SRx Health Solutions, Inc. (0001471727) (Issuer)

    5/7/25 4:56:51 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    EMJX Enhances Gen2 Digital Asset Treasury Operating System On OpenAI's Large Language Models (LLMs) for Research and Risk Decision Support

    NORTH PALM BEACH, Fla., Dec. 19, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), which recently announced a definitive agreement to acquire EMJ Crypto Technologies ("EMJX"), today announced that EMJX is enhancing its Gen2 digital-asset treasury operating system through the integration of OpenAI's latest-generation large language models (LLMs) to support internal research workflows and risk-management decision support. EMJX is a digital-asset treasury operating system that applies quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. The platform is led by Eric M. Jackson and is built to manag

    12/19/25 9:10:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    Platforms, Proof, and Momentum

    DENVER, Dec. 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions (NYSE:SRXH): A Strategic Pivot Toward Gen2 Digital Treasuries SRx Health Solutions (NYSE:SRXH) headlines the morning with a definitive agreement to acquire EMJ Crypto Technologies (EMJX), marking a transformative shift from traditional healthcare operations toward a next-generation digital-asset treasury platform. The transaction positions SRXH at the intersection of public-market governance and quantitative, AI-enabled treasury management, with closing expected in the first quarter of 2026 pending shareholder approval. Until then, shares will continue trading under the SRXH ticker, with the combined company planning to oper

    12/16/25 9:45:19 AM ET
    $AMCI
    $RILY
    $SRXH
    Home Furnishings
    Consumer Discretionary
    Investment Managers
    Finance

    SRx Health Enters into Definitive Agreement to Acquire EMJX to Establish Next-Generation Digital Asset Treasury Operating System and Platform Led by Eric M. Jackson

    NORTH PALM BEACH, Fla., Dec. 16, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced that it has entered into a definitive agreement to acquire EMJ Crypto Technologies ("EMJX"), a digital-asset treasury platform designed as a treasury operating system, applying quantitative models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. Upon completion of the transaction, Eric M. Jackson, Ph.D., Founder and Chief Executive Officer of EMJX, is expected to serve as Chief Executive Officer and Chairman of the combined company. A Gen2 Approach to Digital Asset Treasuries:EMJX is designed as a next-generation

    12/16/25 8:30:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    SEC Filings

    View All

    SEC Form 424B3 filed by SRX Health Solutions Inc.

    424B3 - SRx Health Solutions, Inc. (0001471727) (Filer)

    12/16/25 9:07:36 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRX Health Solutions Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SRx Health Solutions, Inc. (0001471727) (Filer)

    12/16/25 8:47:59 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SEC Form EFFECT filed by SRX Health Solutions Inc.

    EFFECT - SRx Health Solutions, Inc. (0001471727) (Filer)

    12/16/25 12:15:19 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Leadership Updates

    Live Leadership Updates

    View All

    SRx Health Solutions Appoints Sammy Dorf to Board of Directors

    TAMPA, Fla., Nov. 10, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Sammy Dorf, Esq. to its Board of Directors. Sammy is a pioneering force in the modern cannabis economy and one of the industry's most accomplished dealmakers, strategists, and growth architects. Most recently serving as Executive Chairman of Flora Growth Corp. (NASDAQ:FLGC), Sammy guided the company through a transformative phase marked by innovation, disciplined expansion, and a strategic transition into a crypto treasury company. With nearly a decade of leadership at the intersection of cannabis, capital markets, and strategic development, Sammy b

    11/10/25 8:00:00 AM ET
    $FLGC
    $SRXH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Appoints Joshua Epstein to Board of Directors and Compensation Committee

    TAMPA, Fla., Oct. 01, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") today announced the appointment of Joshua Epstein to the Board of Directors and Compensation Committee. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current

    10/1/25 8:00:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions Obtains Initial Order under CCAA for its Canadian Subsidiary

    TAMPA, Fla., Aug. 12, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced that its subsidiary, SRx Health Solutions (Canada), Inc.("SRx Canada") and certain of its subsidiaries obtained an Initial Order (the "Initial Order") in Canada under the federal Companies' Creditors Arrangement Act (the "CCAA" and SRx Canada's proceedings thereunder, the "CCAA Proceedings") from the Ontario Superior Court of Justice (Commercial List) (the "Court"). In connection with the Initial Order, the Court granted, among other relief: a stay of proceedings in favor of SRx Canadathe appointment of Grant Thornton Limited

    8/12/25 2:48:32 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    $SRXH
    Financials

    Live finance-specific insights

    View All

    SRx Health Solutions Announces First Quarter 2025 Financial Results

    EPS Improved 90% Year-Over-Year to $(0.37) Adjusted EBITDA1 Loss Improved 54% Year-Over-Year to $(0.6) Million Adjusted EBITDA Margin1 Improved (9)%, a 865 Basis Point Expansion Year-Over-Year TAMPA, Fla., May 15, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions Inc. (NYSE:SRXH) (the "Company" or "SRx", previously known as "Better Choice"), a leading global health and wellness company, today announced its results for the first quarter ended March 31, 2025. "We have executed a digital first strategy in our domestic business and have implemented marketing investment shifts to grow brand awareness and discoverability," says Kent Cunningham, CEO of SRx. "We are focused on optimizing our port

    5/15/25 4:05:00 PM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples

    SRx Health Solutions to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET

    TAMPA, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company"), a leading global health and wellness company, today announced it will host a conference call and webcast on Thursday, May 15, 2025, at 4:30 p.m. ET to discuss its financial results for the first quarter 2025 and provide a business update. Conference Call and Webcast Information:Event: First Quarter 2025 Financial Results Conference CallDate: Thursday, May 15, 2025Time: 4:30 p.m. Eastern TimeLive Call: 1-844-825-9789 or 1-412-317-5180Webcast:  https://srxhealth.com/events-and-presentations/ For interested individuals unable to join the conference call, the webcast replay of the call will

    5/6/25 8:45:00 AM ET
    $SRXH
    Beverages (Production/Distribution)
    Consumer Staples